产品信息
|
| 中文名 |
(1S,2S,3S,5S)-5-(2-氨基-6-苄氧基-9H-嘌呤-9-基)-3-苄氧基-2-苄氧基甲基环戊醇 |
| 中文同义 |
恩替卡韦-4;恩替卡韦中间体四;恩替卡韦中间体N4;[1S-(1Α,2Β,3Α,5Β)]-5-[2-氨基-6-(苯甲;(1S,2S,3S,5S)-5-(2-氨基-6-苄氧基-9H-嘌呤-9-基)-3-苄氧基-2-苄氧基甲基环戊醇N-6;(1S,2S,3S,5S)-5-(2-氨基-6-苄氧基-9H-嘌呤-9-基)-3-苄氧基-2;(1S,2R,3S,5S)-5-(2-氨基-6-苄氧基-9H-嘌呤-9-基)-3-苄氧基-2-苄氧基甲基环戊醇;(1S,2S,3S,5S)-5-(2-氨基-6-(苯甲氧基)-9H-嘌呤-9-基)-3-(苯甲氧基)-2-(苯甲氧基甲基)环戊醇 |
| 英文名 |
(1S,2S,3S,5S)-5-(2-Amino-6-(benzyloxy)-9H-purin-9-yl)-3-(benzyloxy)-2-(benzyloxymethyl)cyclopentanol |
| 英文同义 |
(1S,2S,3S,5S)-5-(2-Amino-6-(benzyloxy)-9H-purin-9-yl)-3-(benzyloxy)-2-(benzyloxymethyl)cydopentanol;(1S,2S,3S,5S)-5-(2-Amino-6-(benzyloxy)-9H-purin-9-yl)-3-(benzyloxy)-2-(benzyloxymethyl)cyclopentanol;(1S,2S,3S,5S)-5-(2-Amino-6-(benzyloxy)-9H-purin-9-yl)-3-(benzyloxy)-2-(benzyloxymethyl)cyclopentanol ,98%;（1S,2R,3S,5S）-5-(2-amino-6-(benzyloxy)-9H-purin-9-yl)-3-(benzyloxy)-2-(benzyloxymethyl)cyclopentanol;ETD/ET4/N4;(1S,2S,3S,5S)-5-(2-amino-6-phenylmethoxy-9-purinyl)-3-phenylmethoxy-2-(phenylmethoxymethyl)-1-cyclopentanol;(1S,2S,3S,5S)-5-[2-amino-6-(benzyloxy)-9H-purin-9-yl]-3-(benzyloxy)-2-[(benzyloxy)methyl]cyclopentan-1-ol;(1S,2S,3S,5S)-5-(2-AMino-6-(benzyloxy)-9H-purin-9-yl)-3-(benzyloxy)-2-(benzyloxyMethyl)cyclopentanol (interMediate step 3) |
| CAS |
142217-77-4 |
| 分子式 |
C32H33N5O4 |
| 分子量 |
551.64 |
| EINECS |
1312995-182-4 |
| 相关类别 |
抗病毒;医药中间体;中间体 |
| 结构式 |
 |
性质
|
| 沸点 |
780.5±70.0 °C(Predicted) |
| 密度 |
1.33 |
| 酸度系数(pKa) |
13.88±0.70(Predicted) |
